Damora Therapeutics, Inc. (DMRA)vsRevolution Medicines Inc (RVMD)
DMRA
Damora Therapeutics, Inc.
$25.36
-1.17%
HEALTHCARE · Cap: $1.46B
RVMD
Revolution Medicines Inc
$144.12
+2.54%
HEALTHCARE · Cap: $29.88B
Smart Verdict
WallStSmart Research — data-driven comparison
RVMD leads profitability with a 0.0% profit margin vs 0.0%. RVMD earns a higher WallStSmart Score of 24/100 (F).
DMRA
Avoid17
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Safe zone — low bankruptcy risk
Areas to Watch
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Trading at 17.4x book value
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : DMRA
DMRA has a balanced fundamental profile.
Bull Case : RVMD
The strongest argument for RVMD centers on Altman Z-Score.
Bear Case : DMRA
The primary concerns for DMRA are Revenue Growth, EPS Growth, Market Cap.
Bear Case : RVMD
The primary concerns for RVMD are Price/Book, EPS Growth, Profit Margin.
Key Dynamics to Monitor
DMRA carries more volatility with a beta of 1.60 — expect wider price swings.
DMRA is growing revenue faster at 0.0% — sustainability is the question.
DMRA generates stronger free cash flow (566,000), providing more financial flexibility.
Monitor BIOTECHNOLOGY industry trends, competitive dynamics, and regulatory changes.
Bottom Line
RVMD scores higher overall (24/100 vs 17/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Damora Therapeutics, Inc.
HEALTHCARE · BIOTECHNOLOGY · USA
Damora Therapeutics, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company is headquartered in Copenhagen, Denmark.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?